Journal article · Pediatric← The news desk

✦ The Dispatch

The association between hearing loss and treatment requiring retinopathy of prematurity in preterm infants

A dispatch from PubMed — filed

The study aimed to evaluate the association between retinopathy of prematurity (ROP) and hearing loss in preterm infants.

Clinical Takeaway

Clinicians caring for preterm infants who required ROP treatment should be aware of a potential association with hearing loss, supporting thorough audiology follow-up screening in this population; however, the retrospective design limits causal conclusions.

Why It Matters

Identifying co-occurrence of ROP treatment and hearing loss in preterm infants could help prioritize high-risk neonates for early audiology screening and multidisciplinary follow-up.

Key Points
  1. 01Retrospective design examining hearing loss rates in preterm infants who needed ROP treatment.
  2. 02Both ROP and hearing loss share common risk factors in prematurity (e.g., low gestational age, NICU interventions).
  3. 03Findings may support integrated screening protocols for preterm infants with severe ROP.
  4. 04Published in American Journal of Otolaryngology (2026).
  5. 05Causal direction cannot be established from a retrospective study.
Claims & Evidence

Treatment-requiring retinopathy of prematurity is associated with hearing loss in preterm infants.

studypartially supported
Research metadata
PMID
42208094
DOI
10.1016/j.amjoto.2026.104861.
Journal
American Journal of Otolaryngology
Publication type
research_article
Evidence level
4
Population
Preterm infants with treatment-requiring retinopathy of prematurity
Intervention
Presence of treatment-requiring retinopathy of prematurity
Comparator
Preterm infants without treatment-requiring ROP

Primary outcomes

Prevalence/association of hearing loss in preterm infants with treatment-requiring ROP

Related stories